Table 3.
The characteristics of PCP cases involved in an outbreak
| Patients | Age range | Primary diseases | Date of diagnosis | Time since transplant (w) | Sample type | Outcome |
|---|---|---|---|---|---|---|
| P1 | 66-70 | HCC | 7.19.2015 | 9 | sputum | Dead |
| P2 | 61-65 | HCC | 9.9.2015 | 8 | sputum | Dead |
| P3 | 51-55 | HCC | 3.24.2016 | 21 | sputum | Alive |
| P4 | 61-65 | Cirrhosis | 7.26.2016 | 15 | BALF | Dead |
| P5 | 36-40 | Cirrhosis | 4.1.2018 | 51 | sputum | Alive |
| P6 | 26-30 | Cirrhosis | 6.21.2018 | 21 | BALF | Dead |
| P7 | 51-55 | Cirrhosis | 8.17.2018 | 1 | sputum | Alive |
| P8 | 56-60 | HCC | 10.3.2018 | 19 | sputum | Alive |
| P9 | 61-65 | HCC | 12.15.2018 | 17 | sputum | Alive |
| P10 | 61-65 | HCC | 1.14.2019 | 10 | sputum | Alive |
PCP, Pneumocystis pneumonia; HCC, hepatic cell carcinoma; BALF, bronchoalveolar lavage fluid.